CLINICAL_TRIALS
trial_result
· 2012-03-06
Clinical Trial Update: Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) [Phase 3]
Summary
This clinical trial update reports the completion of a Phase 3 study evaluating temsirolimus (CCI-779) in mantle cell lymphoma, with results posted in March 201…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2012-03-06